Daniel R. Chard - Feb 22, 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Feb 22, 2022
Transactions value $
-$546,407
Form type
4
Date filed
2/24/2022, 08:06 PM
Previous filing
Apr 21, 2022
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability -$319K -1.8K -11.48% $177.06 13.9K Feb 22, 2022 Direct F1, F2
transaction MED Common Stock Tax liability -$227K -1.28K -9.22% $177.06 12.6K Feb 22, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares vested on February 19, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.
F2 Pursuant to the terms of the Issuer's Amended and Restated 2012 Share Incentive Plan, the price was the closing sales price for the most recent trading day prior to the vesting date.
F3 These shares vested on February 20, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022.